Ethos Technologies Inc. (NASDAQ:LIFE) Q1 2026 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Ethos Technologies Inc. Q1 2026 Earnings Call. At this time, all participants are in a listen-only mode.
Ethos Technologies Inc. (LIFE)
Market is closed
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.00 | 260,525 | $4,949,975.00 | 260,525 | 2026-01-29 | Filing | |
| $19.00 | 260,525 | $4,949,975.00 | 271,025 | 2026-01-30 | Filing | |
| $19.00 | 5,263 | $99,997.00 | 17,451 | 2026-01-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.90 | 118,138 | $2,232,760.94 | 0 | 2026-07-28 | Filing | |
| $19.46 | 196,931 | $3,832,848.36 | 0 | 2026-07-27 | Filing | |
| $18.88 | 23,417 | $442,000.56 | 0 | 2026-07-24 | Filing | |
| $19.06 | 63,297 | $1,206,269.92 | 0 | 2026-07-23 | Filing | |
| $19.23 | 49,582 | $953,466.82 | 0 | 2026-07-22 | Filing |
News See All
Ethos Technologies Inc. (NASDAQ:LIFE) Q1 2026 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Ethos Technologies Inc. Q1 2026 Earnings Call. At this time, all participants are in a listen-only mode.
Citi Raises Ethos Technologies Inc. (LIFE) Price Target to $16 from $15
On February 26, Citi raised the firm’s price target on Ethos Technologies Inc.
11 Best Low Priced Growth Stocks to Buy Right Now
Low-priced growth stocks, specifically those combining a low forward P/E ratio with strong or accelerating Earnings Per Share (EPS), offer a compelling blend of value and momentum.
aTyr Pharma, Inc. (NASDAQ:LIFE) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the aTyr Pharma fourth quarter and full year 2023 conference call. At this time, all participants are in a listen only mode.
5 Most Promising Penny Stocks According to Analysts
Germany-based Affimed N.V. (NASDAQ:AFMD) is working on cancer immunotherapies. Affimed N.V.
aTyr Pharma, Inc. (NASDAQ:LIFE) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the aTyr Pharma Fourth Quarter and Full Year 2022 Conference Call. At this time, all participants are in a listen-only mode.
aTyr Pharma, Inc. (NASDAQ:LIFE) Q3 2022 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen and welcome to aTyr Pharma's Third Quarter 2022 Conference Call. At this time, all participants are in a listen-only mode.
10 Best Pharma Stocks To Buy Now
With a compound annual growth rate (CAGR) of 9.1%, the global pharmaceuticals industry is projected to expand to $1587.1 billion in 2022 from $1454.7 billion in 2021.
Hedge Fund and Insider Trading News: John Paulson, Michael Burry, Mike Novogratz, Paul Singer, Bluebell Capital Partners, Tiger Global Management, ExodusPoint Capital, Crowdstrike Holdings Inc (CRWD), aTyr Pharma Inc (LIFE), and More
Billionaire crypto investor Mike Novogratz has said bitcoin holding firm at $40,000 during the recent sell-off is a good sign for the market, and recommended buying the dip in digital assets.
Hedge Fund Resource Center